Analyst Alex Arfaei is focused on the Healthcare sector with 311 price targets and ratings documented since 2012 spanning on 8 stocks. Previously, Alex Arfaei worked at BMO. Analyst's average stock valuation to be materialised ratio is 97.11% with an average time for price targets to be met of 524.75 days.
Most recent stock forecast was given on ZTS, Zoetis Inc at 09-May-2019.
Alex Arfaei best performing recommendations are on KIN.
The best stock recommendation documented was for KIN at 1/6/2014. The price target of $15 was fulfilled within 9 days with a profit of $4.61 (44.37%) receiving and performance score of 49.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
157
$12.16 (8.40%)
155
18 days ago
33/34 (97.06%)
$24.49 (29.07%)
425
Buy
182
$37.16 (25.66%)
178
1 months 29 days ago
14/22 (63.64%)
$25.08 (28.76%)
561
Hold
140
$-4.84 (-3.34%)
172
2 months 27 days ago
0/2 (0%)
$25.87 (23.60%)
Hold
155
$10.16 (7.01%)
160
3 months 4 days ago
7/8 (87.5%)
$12.27 (10.71%)
76
Buy
169
$24.16 (16.68%)
174
3 months 4 days ago
11/13 (84.62%)
$16.17 (14.62%)
118
